The novel pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of care

1. Paíno, T.
2. Garcia-Gomez, A.
3. González-Méndez, L.
4. San-Segundo, L.
5. Hernández-García, S.
6. López-Iglesias, A.-A.
7. Algarín, E.M.
8. Martín-Sánchez, M.
9. Corbacho, D.
10. Ortiz-De-Solorzano, C.
11. Corchete, L.A.
12. Gutiérrez, N.C.
13. Maetos, M.-V.
14. Garayoa, M.
15. Ocio, E.M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1158/1078-0432.CCR-16-0230 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus